344-Murata-InfectHeart/Fig2D_hypoxia
Author reviewed
Immunofluorescence images for persistent infection model of SARS-CoV-2 after 18h of hypoxia treatment followed by 48h reperfusion treatment
Title
Immunofluorescence images for persistent infection model of SARS-CoV-2 after 18h of hypoxia treatment followed by 48h reperfusion treatment
Description
Immunofluorescence images for persistent infection model of SARS-CoV-2 after 18h of hypoxia treatment (low-oxygen environment , <0.1% oxygen concentration) followed by 48h reperfusion treatment. cTnT (green), S protein (red), and DAPI (blue).
X Scale
566 micrometer/pixel
Y Scale
566 micrometer/pixel
Biosample
Description
Human iPS cell-derived cardiac microtissues. They are composed of cardiomyocytes and other cardiac component cells (vascular endothelial cells and vascular mural cells) differentiated from human iPS cells and yield a vascular network-like structure that morphologically and functionally mimics the human heart.
Cell
differentiated iPS cells
Ontology
Genetics
Treatments
Reagent / Compound
SARS-CoV-2/UT-NCGM02/Human/2020/Tokyo
Imaging Method
Detection Method
wide-field detection
Visualization Method
Alexa 488, Alexa 546
Illumination Method
continuous illumination
Source of Contrast
differences in adsorption or binding of stain
Imaged Parameter
fluorescence emission
Sample Preparation Method
fixation method
Instrument
Objective
KEYENCE PlanFluorite LD 40x 0.60-3.30-2.20mm Ph2:Default